Nutrient Availability as a Driver of Transcriptome Reprogramming in Osteosarcoma
Background: Gene expression in mammalian cells is intricately regulated by environmental and metabolic cues. Among these, nutrient availability represents a key feature of the tumor microenvironment and has recently emerged as a potent modulator of oncogenic signaling networks. In this study, we employed a cell-line model of osteosarcoma, a rare but highly aggressive bone malignancy affecting…
Osteosarcoma, a rare and aggressive bone cancer, demonstrates how nutrient availability can profoundly alter gene expression, opening new avenues for therapeutic intervention. By altering the concentration of a single nutrient, researchers observed a significant reprogramming of gene expression in osteosarcoma cells. This nutrient-dependent transcriptional response was analyzed through bulk RNA sequencing of an osteosarcoma cell line, cultured under varying concentrations of the key nutrients glucose and glutamine.
Differential gene expression analysis revealed that these nutrients have a pronounced effect on gene regulation, with several genes identified as being functionally associated with cancer-related pathways.
Interestingly, the study identified seven distinct expression patterns, one of which showed a strong correlation with cell growth rate and resembled a transcriptional signature similar to FOS. The proto-oncogene FOS emerged as a key player, with its expression pattern tightly linked to cell growth. These findings highlight the importance of nutrient-responsive targets for potential therapeutic purposes.
The results expand our understanding of metabolic regulation in cancer and suggest that nutrient-based interventions could be a controlled means to influence tumor progression. The implications extend beyond oncology, potentially impacting developmental biology, autoimmune disorders, and nervous system function. This study underscores the therapeutic potential of metabolic interventions as a strategy for targeted modulation of gene expression programs in various diseases.
Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
